CyberIntel ⬡ News
★ Saved ◆ Cyber Reads
← Back ◬ AI & Machine Learning Apr 27, 2026

MolClaw: An Autonomous Agent with Hierarchical Skills for Drug Molecule Evaluation, Screening, and Optimization

arXiv AI Archived Apr 27, 2026 ✓ Full text saved

arXiv:2604.21937v1 Announce Type: new Abstract: Computational drug discovery, particularly the complex workflows of drug molecule screening and optimization, requires orchestrating dozens of specialized tools in multi-step workflows, yet current AI agents struggle to maintain robust performance and consistently underperform in these high-complexity scenarios. Here we present MolClaw, an autonomous agent that leads drug molecule evaluation, screening, and optimization. It unifies over 30 speciali

Full text archived locally
✦ AI Summary · Claude Sonnet


    Computer Science > Artificial Intelligence [Submitted on 2 Apr 2026] MolClaw: An Autonomous Agent with Hierarchical Skills for Drug Molecule Evaluation, Screening, and Optimization Lisheng Zhang, Lilong Wang, Xiangyu Sun, Wei Tang, Haoyang Su, Yuehui Qian, Qikui Yang, Qingsong Li, Zhenyu Tang, Haoran Sun, Yingnan Han, Yankai Jiang, Wenjie Lou, Bowen Zhou, Xiaosong Wang, Lei Bai, Zhengwei Xie Computational drug discovery, particularly the complex workflows of drug molecule screening and optimization, requires orchestrating dozens of specialized tools in multi-step workflows, yet current AI agents struggle to maintain robust performance and consistently underperform in these high-complexity scenarios. Here we present MolClaw, an autonomous agent that leads drug molecule evaluation, screening, and optimization. It unifies over 30 specialized domain resources through a three-tier hierarchical skill architecture (70 skills in total) that facilitates agent long-term interaction at runtime: tool-level skills standardize atomic operations, workflow-level skills compose them into validated pipelines with quality check and reflection, and a discipline-level skill supplies scientific principles governing planning and verification across all scenarios in the field. Additionally, we introduce MolBench, a benchmark comprising molecular screening, optimization, and end-to-end discovery challenges spanning 8 to 50+ sequential tool calls. MolClaw achieves state-of-the-art performance across all metrics, and ablation studies confirm that gains concentrate on tasks that demand structured workflows while vanishing on those solvable with ad hoc scripting, establishing workflow orchestration competence as the primary capability bottleneck for AI-driven drug discovery. Comments: 59 pages, 10 figures. Code and data will be released Subjects: Artificial Intelligence (cs.AI); Multiagent Systems (cs.MA) Cite as: arXiv:2604.21937 [cs.AI]   (or arXiv:2604.21937v1 [cs.AI] for this version)   https://doi.org/10.48550/arXiv.2604.21937 Focus to learn more Submission history From: Xiangyu Sun [view email] [v1] Thu, 2 Apr 2026 09:27:36 UTC (32,314 KB) Access Paper: HTML (experimental) view license Current browse context: cs.AI < prev   |   next > new | recent | 2026-04 Change to browse by: cs cs.MA References & Citations NASA ADS Google Scholar Semantic Scholar Export BibTeX Citation Bookmark Bibliographic Tools Bibliographic and Citation Tools Bibliographic Explorer Toggle Bibliographic Explorer (What is the Explorer?) Connected Papers Toggle Connected Papers (What is Connected Papers?) Litmaps Toggle Litmaps (What is Litmaps?) scite.ai Toggle scite Smart Citations (What are Smart Citations?) Code, Data, Media Demos Related Papers About arXivLabs Which authors of this paper are endorsers? | Disable MathJax (What is MathJax?)
    💬 Team Notes
    Article Info
    Source
    arXiv AI
    Category
    ◬ AI & Machine Learning
    Published
    Apr 27, 2026
    Archived
    Apr 27, 2026
    Full Text
    ✓ Saved locally
    Open Original ↗